Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Depreciation & Amortization (CF) (2019 - 2025)

Historic Depreciation & Amortization (CF) for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • Korro Bio's Depreciation & Amortization (CF) rose 3333.33% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 4838.42%. This contributed to the annual value of $3.6 million for FY2024, which is 82.64% down from last year.
  • Per Korro Bio's latest filing, its Depreciation & Amortization (CF) stood at $1.2 million for Q3 2025, which was up 3333.33% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Depreciation & Amortization (CF) peaked at $1.3 million during Q4 2024, and registered a low of $382000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $735000.0 (2021), whereas its average is $799894.7.
  • As far as peak fluctuations go, Korro Bio's Depreciation & Amortization (CF) soared by 27745.9% in 2021, and later crashed by 4341.93% in 2022.
  • Korro Bio's Depreciation & Amortization (CF) (Quarter) stood at $737000.0 in 2021, then plummeted by 43.42% to $417000.0 in 2022, then skyrocketed by 136.21% to $985000.0 in 2023, then skyrocketed by 30.76% to $1.3 million in 2024, then dropped by 6.83% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.2 million for Q2 2025, and $1.2 million during Q1 2025.